Aura Biosciences, Inc. AURA Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s change in accrued liabilities?
- Aura Biosciences, Inc. (AURA) reported change in accrued liabilities of -$2.75M in Q1 2026.
- How has Aura Biosciences, Inc.'s change in accrued liabilities changed year-over-year?
- Aura Biosciences, Inc.'s change in accrued liabilities decreased by 10.9% year-over-year, from -$2.48M to -$2.75M.
- What is the long-term trend for Aura Biosciences, Inc.'s change in accrued liabilities?
- Over 2 years (2021 to 2025), Aura Biosciences, Inc.'s change in accrued liabilities has grown at a 38.9% compound annual growth rate (CAGR), from $2.21M to $4.26M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.